"Azetidines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
No definition found.
Below are MeSH descriptors whose meaning is more general than "Azetidines".
Below are MeSH descriptors whose meaning is more specific than "Azetidines".
This graph shows the total number of publications written about "Azetidines" by people in Harvard Catalyst Profiles by year, and whether "Azetidines" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 0 | 1 | 1 |
2001 | 1 | 0 | 1 |
2002 | 1 | 0 | 1 |
2003 | 1 | 1 | 2 |
2004 | 1 | 1 | 2 |
2005 | 2 | 1 | 3 |
2006 | 3 | 0 | 3 |
2007 | 2 | 2 | 4 |
2008 | 4 | 1 | 5 |
2009 | 3 | 0 | 3 |
2010 | 5 | 3 | 8 |
2011 | 5 | 1 | 6 |
2012 | 7 | 3 | 10 |
2013 | 1 | 2 | 3 |
2014 | 2 | 3 | 5 |
2015 | 4 | 1 | 5 |
2016 | 2 | 1 | 3 |
2017 | 3 | 1 | 4 |
2018 | 4 | 1 | 5 |
2019 | 5 | 4 | 9 |
2020 | 4 | 4 | 8 |
2021 | 1 | 4 | 5 |
2022 | 0 | 2 | 2 |
2023 | 1 | 0 | 1 |
2024 | 1 | 0 | 1 |
Below are the most recent publications written about "Azetidines" by people in Profiles.
-
Long-term efficacy and safety of baricitinib in patients with severe alopecia areata: 104-week results from BRAVE-AA1 and BRAVE-AA2. J Eur Acad Dermatol Venereol. 2024 Mar; 38(3):583-593.
-
PREVLAR: Phase 2a Randomized Trial to Assess the Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Head and Neck Chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2023 07 01; 116(3):551-559.
-
JAK inhibitor blocks COVID-19 cytokine-induced JAK/STAT/APOL1 signaling in glomerular cells and podocytopathy in human kidney organoids. JCI Insight. 2022 06 08; 7(11).
-
Baricitinib attenuates the proinflammatory phase of COVID-19 driven by lung-infiltrating monocytes. Cell Rep. 2022 06 14; 39(11):110945.
-
Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial. Lancet Respir Med. 2022 09; 10(9):888-899.
-
Advances in clinical outcomes: What we have learned during the COVID-19 pandemic. J Allergy Clin Immunol. 2022 02; 149(2):569-578.
-
Multicenter randomized phase II trial of atezolizumab with or without cobimetinib in biliary tract cancers. J Clin Invest. 2021 12 15; 131(24).
-
Novel Reversible-Binding PET Ligands for Imaging Monoacylglycerol Lipase Based on the Piperazinyl Azetidine Scaffold. J Med Chem. 2021 10 14; 64(19):14283-14298.
-
Sustained Tumor Control With MAPK Inhibition in BRAF V600-Mutant Adult Glial and Glioneuronal Tumors. Neurology. 2021 08 17; 97(7):e673-e683.
-
Combination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASH. Hepatology. 2021 02; 73(2):625-643.